InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

MA

Mia Arnhult

Director

BoardF

Devyser Diagnostics AB Logistea AB (publ)Logistea AB (publ)Devyser Diagnostics AB Meds Apotek AB Meds Apotek AB

Cumul. flow

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the complete record of transactions filed by Mia Arnhult, Director. Insider active across 6 companies, notably Devyser Diagnostics AB. Cumulatively, 18 filings have been logged. Activity tracked since 3 March 2025. The latest transaction was disclosed on 20 March 2026 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.

Declarations18 total

●

StyrelseordförandeExecutives20 Mar 2026Devyser Diagnostics AB

€3,57416FI-SE ↗

500 shares@ €7.14810.0002% mcap0.5% of flowAktieFI:A003X205-1

Ideal exit: 15 Dec 2026 (T+270)

●

StyrelseledamotExecutives18 Feb 2026Devyser Diagnostics AB

€90,77817FI-SE ↗

9,802 shares@ €9.26120.0060% mcap12.4% of flowAktieFI:A003W323-1

●

StyrelseordförandeExecutives21 Nov 2025Devyser Diagnostics AB

€1,28620FI-SE ↗

135 shares@ €9.52550.0001% mcap0.9% of flowAktieFI:A003U153-1

Ideal exit: 18 Aug 2026 (T+270)

●

StyrelseordförandeExecutives7 Nov 2025Devyser Diagnostics AB

€140,63829FI-SE ↗

14,084 shares@ €9.98570.0093% mcap95.6% of flowAktieFI:A003T495-1

Ideal exit: 4 Aug 2026 (T+270)

●

StyrelseledamotExecutives28 Oct 2025Meds Apotek AB

€3M37FI-SE ↗

622,641 shares@ €4.84880.74% mcap100.0% of flowAktieFI:A003T179-1

●

StyrelseledamotExecutives22 Sept 2025Logistea AB (publ)

€66,98421FI-SE ↗

50,000 shares@ €1.33970.0010% mcap2.5% of flowAktieFI:A003S582-1

●

StyrelseledamotExecutives22 Sept 2025Meds Apotek AB

€2M36FI-SE ↗

403,049 shares@ €4.79750.48% mcap100.0% of flowAktieFI:A003S539-1

●

StyrelseledamotExecutives15 Sept 2025Logistea AB (publ)

€2M30FI-SE ↗

1,250,000 shares@ €1.32790.024% mcap61.5% of flowAktieFI:A003S423-1

Ideal exit: 12 Jun 2026 (T+270)

●

StyrelseledamotExecutives10 Sept 2025Logistea AB (publ)

€342,65626FI-SE ↗

250,000 shares@ €1.37060.0049% mcap12.7% of flowAktieFI:A003S245-1

Ideal exit: 7 Jun 2026 (T+270)

●

StyrelseordförandeExecutives11 Sept 2025Devyser Diagnostics AB

€569,43236FI-SE ↗

41,596 shares@ €13.68960.038% mcap77.9% of flowAktieFI:A003S223-1

●

StyrelseledamotExecutives9 Jun 2025Logistea AB (publ)

€133,53925FI-SE ↗

100,000 shares@ €1.33540.0019% mcap4.9% of flowAktieFI:A003P696-2

●

StyrelseledamotExecutives4 Jun 2025Logistea AB (publ)

€188,23426FI-SE ↗

146,470 shares@ €1.28510.0027% mcap7.0% of flowAktieFI:A003P364-1

Ideal exit: 1 Mar 2026 (T+270)

●

StyrelseledamotExecutives19 May 2025Logistea AB (publ)

€30,20033FI-SE ↗

23,500 shares@ €1.28510.0004% mcap83.4% of flowAktieFI:A003O586-1

Ideal exit: 13 Feb 2026 (T+270)

●

StyrelseledamotExecutives8 May 2025Logistea AB (publ)

€306,34122FI-SE ↗

228,643 shares@ €1.33980.0044% mcap11.3% of flowAktieFI:A003O089-1

Ideal exit: 2 Feb 2026 (T+270)

●

StyrelseledamotExecutives14 Mar 2025Logistea AB (publ)

€2,39721FI-SE ↗

2,000 shares@ €1.19860.0000% mcap0.1% of flowAktieFI:A003M658-1

Ideal exit: 9 Dec 2025 (T+270)

●

StyrelseordförandeExecutives14 Mar 2025Devyser Diagnostics AB

€67,31721FI-SE ↗

7,000 shares@ €9.61670.0045% mcap9.2% of flowAktieFI:A003M659-1

Ideal exit: 9 Dec 2025 (T+270)

●

StyrelseordförandeExecutives10 Mar 2025Devyser Diagnostics AB

€5,24013FI-SE ↗

500 shares@ €10.47980.0003% mcap3.6% of flowAktieFI:A003M385-1

Ideal exit: 5 Dec 2025 (T+270)

●

StyrelseledamotExecutives3 Mar 2025Logistea AB (publ)

€6,00616FI-SE ↗

4,586 shares@ €1.30960.0001% mcap16.6% of flowAktieFI:A003M152-1

Ideal exit: 28 Nov 2025 (T+270)

18 of 18 declarations

About Mia Arnhult

Mia Arnhult is a board member at Logistea AB (publ). She contributes to the governance of the company, which specializes in real estate development. Mia Arnhult plays a key role in strategic decision-making and developing the company's policies.